-
Something wrong with this record ?
Acridine Based N-Acylhydrazone Derivatives as Potential Anticancer Agents: Synthesis, Characterization and ctDNA/HSA Spectroscopic Binding Properties
M. Vilková, M. Hudáčová, N. Palušeková, R. Jendželovský, M. Almáši, T. Béres, P. Fedoročko, M. Kožurková
Language English Country Switzerland
Document type Journal Article
Grant support
VEGA Grant No. 1/00037/22
Scientific Grant Agency of the Ministry of Education
NLK
Directory of Open Access Journals
from 1997
Free Medical Journals
from 1997
PubMed Central
from 2001
Europe PubMed Central
from 2001
ProQuest Central
from 1997-01-01
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 2009-03-01
Health & Medicine (ProQuest)
from 1997-01-01
- MeSH
- Acridines chemistry MeSH
- Topoisomerase II Inhibitors pharmacology MeSH
- Intercalating Agents MeSH
- Humans MeSH
- Serum Albumin, Human chemistry MeSH
- Antineoplastic Agents * chemistry MeSH
- Binding Sites MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
A series of novel acridine N-acylhydrazone derivatives have been synthesized as potential topoisomerase I/II inhibitors, and their binding (calf thymus DNA-ctDNA and human serum albumin-HSA) and biological activities as potential anticancer agents on proliferation of A549 and CCD-18Co have been evaluated. The acridine-DNA complex 3b (-F) displayed the highest Kb value (Kb = 3.18 × 103 M-1). The HSA-derivatives interactions were studied by fluorescence quenching spectra. This method was used for the calculation of characteristic binding parameters. In the presence of warfarin, the binding constant values were found to decrease (KSV = 2.26 M-1, Kb = 2.54 M-1), suggesting that derivative 3a could bind to HSA at Sudlow site I. The effect of tested derivatives on metabolic activity of A549 cells evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide or MTT assay decreased as follows 3b(-F) > 3a(-H) > 3c(-Cl) > 3d(-Br). The derivatives 3c and 3d in vitro act as potential dual inhibitors of hTopo I and II with a partial effect on the metabolic activity of cancer cells A594. The acridine-benzohydrazides 3a and 3c reduced the clonogenic ability of A549 cells by 72% or 74%, respectively. The general results of the study suggest that the novel compounds show potential for future development as anticancer agents.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018683
- 003
- CZ-PrNML
- 005
- 20220804134950.0
- 007
- ta
- 008
- 220720s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/molecules27092883 $2 doi
- 035 __
- $a (PubMed)35566236
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Vilková, Mária $u NMR Laboratory, Institute of Chemical Sciences, Faculty of Science, P. J. Šafárik University in Košice, Moyzesova 11, 041 67 Košice, Slovakia $1 https://orcid.org/0000000328337361 $7 xx0233889
- 245 10
- $a Acridine Based N-Acylhydrazone Derivatives as Potential Anticancer Agents: Synthesis, Characterization and ctDNA/HSA Spectroscopic Binding Properties / $c M. Vilková, M. Hudáčová, N. Palušeková, R. Jendželovský, M. Almáši, T. Béres, P. Fedoročko, M. Kožurková
- 520 9_
- $a A series of novel acridine N-acylhydrazone derivatives have been synthesized as potential topoisomerase I/II inhibitors, and their binding (calf thymus DNA-ctDNA and human serum albumin-HSA) and biological activities as potential anticancer agents on proliferation of A549 and CCD-18Co have been evaluated. The acridine-DNA complex 3b (-F) displayed the highest Kb value (Kb = 3.18 × 103 M-1). The HSA-derivatives interactions were studied by fluorescence quenching spectra. This method was used for the calculation of characteristic binding parameters. In the presence of warfarin, the binding constant values were found to decrease (KSV = 2.26 M-1, Kb = 2.54 M-1), suggesting that derivative 3a could bind to HSA at Sudlow site I. The effect of tested derivatives on metabolic activity of A549 cells evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide or MTT assay decreased as follows 3b(-F) > 3a(-H) > 3c(-Cl) > 3d(-Br). The derivatives 3c and 3d in vitro act as potential dual inhibitors of hTopo I and II with a partial effect on the metabolic activity of cancer cells A594. The acridine-benzohydrazides 3a and 3c reduced the clonogenic ability of A549 cells by 72% or 74%, respectively. The general results of the study suggest that the novel compounds show potential for future development as anticancer agents.
- 650 _2
- $a akridiny $x chemie $7 D000166
- 650 12
- $a protinádorové látky $x chemie $7 D000970
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interkalátory $7 D007364
- 650 _2
- $a lidský sérový albumin $x chemie $7 D000075462
- 650 _2
- $a inhibitory topoisomerasy II $x farmakologie $7 D059005
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hudáčová, Monika $u Department of Biochemistry, Institute of Chemical Sciences, Faculty of Science, P. J. Šafárik University in Košice, Moyzesova 11, 041 67 Košice, Slovakia $1 https://orcid.org/0000000338161654
- 700 1_
- $a Palušeková, Nikola $u Department of Biochemistry, Institute of Chemical Sciences, Faculty of Science, P. J. Šafárik University in Košice, Moyzesova 11, 041 67 Košice, Slovakia
- 700 1_
- $a Jendželovský, Rastislav $u Department of Cellular Biology, Institute of Biology, Faculty of Science, P. J. Šafárik University in Košice, Moyzesova 11, 041 67 Košice, Slovakia $1 https://orcid.org/0000000163380723
- 700 1_
- $a Almáši, Miroslav $u Department of Inorganic Chemistry, Institute of Chemical Sciences, Faculty of Science, P. J. Šafárik University in Košice, Moyzesova 11, 041 67 Košice, Slovakia $1 https://orcid.org/0000000260446683
- 700 1_
- $a Béres, Tibor $u Czech Advanced Technology and Research Institute, Centre of the Region Hana for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 241/27, 779 00 Olomouc, Czech Republic $1 https://orcid.org/0000000258456903
- 700 1_
- $a Fedoročko, Peter $u Department of Cellular Biology, Institute of Biology, Faculty of Science, P. J. Šafárik University in Košice, Moyzesova 11, 041 67 Košice, Slovakia $1 https://orcid.org/0000000211386282 $7 xx0064682
- 700 1_
- $a Kožurková, Mária $u Department of Biochemistry, Institute of Chemical Sciences, Faculty of Science, P. J. Šafárik University in Košice, Moyzesova 11, 041 67 Košice, Slovakia $1 https://orcid.org/0000000283440671
- 773 0_
- $w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 27, č. 9 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35566236 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134943 $b ABA008
- 999 __
- $a ok $b bmc $g 1822347 $s 1169926
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 27 $c 9 $e 20220430 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
- GRA __
- $a VEGA Grant No. 1/00037/22 $p Scientific Grant Agency of the Ministry of Education
- LZP __
- $a Pubmed-20220720